Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease
Study identifies chlorcyclizine as a potential treatment to reduce protoporphyrin-IX accumulation and liver damage in experimental models of EPP.
Study: The histamine pathway is a target to treat hepatic experimental…
Read More...
Read More...